Objective 1
Conduct a Comprehensive Market Assessment
Evaluate the size, growth trajectory, and revenue potential of key medical equipment segments including Diagnostics, Dialysis, and Cancer Therapy.
CASE STUDY
IPO Market Assessment and Strategic Positioning Study for Medilines in the Philippines
Client
Medilines
Engagement Owner
Vice President
Geography
Philippines
Client Context
Medilines
Medilines is a leading provider of specialized medical equipment in the Philippines, delivering advanced diagnostic, dialysis, and cancer therapy solutions to top-tier hospitals and healthcare institutions. The company has built a strong reputation for reliability, service excellence, and technology-driven healthcare solutions that enhance patient outcomes.
As part of its IPO preparation journey, Medilines engaged Ken Research to conduct a comprehensive market assessment of the Philippine medical device industry. The objective was to strengthen its valuation narrative, quantify growth potential, benchmark competitors, and ensure regulatory clarity to support investor confidence.
Engagement Value Pillars
Engagement Objectives
Strategic consulting objectives designed to provide actionable insights and sustainable competitive advantages
Objective 2
Analyze Regulatory and Post-Pandemic Shifts
Assess Philippine regulatory frameworks, import guidelines, and the impact of COVID-19 on procurement cycles, hospital spending, and compliance requirements.
Objective 3
Define Market Segmentation and Positioning for IPO
Develop a robust segmentation and competitive positioning narrative aligned with investor expectations and IPO disclosure requirements.
Our Methodology
Consulting Approach & Initiatives
A systematic, research-driven approach designed to deliver actionable insights and sustainable outcomes
Step 1
A. Demand Estimation & Growth Modeling
Estimated current and forecasted demand for critical medical equipment categories, identifying high-growth therapy segments with strong procurement visibility across public and private healthcare facilities.
Step 2
B. Regulatory & Policy Landscape Assessment
Evaluated Philippine medical device regulations, import licensing requirements, and COVID-driven policy shifts to map compliance risks and long-term market sustainability.
Step 3
C. Competitive Benchmarking & Pricing Analysis
Benchmarked 10+ key competitors across product portfolios, pricing models, customer concentration, and distribution strategies to assess Medilines’ market share expansion potential in premium equipment segments.
Step 4
D. Valuation-Ready Market Narrative Development
Analyzed customer adoption trends, hospital infrastructure expansion, and capital equipment cycles to construct a credible, data-backed growth story for IPO disclosures.
Measurable Business Outcomes
Impact Delivered
01
1. 10+ Competitors Benchmarked
Mapped competitive landscape across premium equipment segments, highlighting Medilines’ positioning and 12–15% market share expansion potential in selected categories.
02
2. USD 40–50 Mn Incremental Revenue Opportunity Identified
Outlined annual revenue upside driven by favorable regulatory support, healthcare infrastructure growth, and post-COVID recovery in capital equipment procurement.
03
3. 9–11% Projected CAGR Across Core Segments
Validated strong medium-term growth outlook in Diagnostics, Dialysis, and Cancer Therapy, strengthening investor confidence in long-term earnings visibility.
Client Endorsement
Vice President, Medilines
4.6/5
4.6/5
— Director, Yash Highvoltage Insulators
Let's Connect
Ready to Unlock Strategic Insights for Your Business?
Engage with Ken Research to explore data-backed perspectives and clarify your next strategic decision.
Related Resources
Industry Insights & Resources
Expert perspectives and thought leadership on market intelligence, strategic consulting, and transformative business solutions